Featured News

Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

The FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.

Join UChicago Celiac Disease Center to discuss serology and the importance of regular follow-up.

The Celiac Disease Foundation is proud to recognize our dedicated volunteers, Francie Wallack and Josh Denney.

Join UChicago Celiac Disease Center via Zoom on Monday, May 2nd, 2022 at 7:00 PM CST to kick off Celiac Awareness Month.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).